Go Pro
OTCMKTS:TINLY

Teijin Q3 2025 Earnings Report

Teijin logo
$10.45 0.00 (0.00%)
As of 10/2/2026

Teijin EPS Results

Actual EPS
$0.02
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Teijin Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Teijin Announcement Details

Quarter
Q3 2025
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

Teijin's next earnings date is estimated for Monday, November 9, 2026, based on past reporting schedules.

Conference Call Resources

Teijin Earnings Headlines

Teijin (TINLF) Receives a Hold from SMBC Nikko
Trump's New Dollar
Porter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. dollar reset - and most Americans don't know it's happening. The last time America underwent a monetary shift like this, under Nixon in the 1970s, it minted an average of 1,300 new millionaires a day for over half a century. Stansberry has released a new documentary naming the assets he believes are positioned to surge as a result.tc pixel
See More Teijin Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Teijin? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Teijin and other key companies, straight to your email.

About Teijin

Teijin (OTCMKTS:TINLY) Limited is a Japan-based technology-driven company whose businesses span advanced materials, fibers and healthcare. Its materials operations develop and manufacture products such as carbon fiber and aramid fibers, resin and composite materials, films, and other high-performance materials used in aerospace, automotive, electronics, construction, and industrial applications.

Through its healthcare business, Teijin provides pharmaceutical products and medical devices, including treatments for respiratory conditions and home healthcare services. The company also develops solutions related to sleep apnea, oxygen therapy, and other areas of chronic disease management.

Founded in Japan in 1918, Teijin has expanded its operations internationally and serves customers across Japan, Asia, Europe, North America, and other global markets. The company combines materials science, healthcare expertise, and information technology to develop products and services focused on sustainability, mobility, and improved quality of life.

View Teijin Profile